Facts behind Color Blindness

Image

Color blindness is not a form of blindness but a deficiency in the way you see color.

If you are colorblind, you have difficulty distinguishing certain colors, such as blue and yellow or red and green.

Color blindness (more accurately color vision deficiency) is an inherited condition that affects males more frequently than females.

Red-green color deficiency is the most common form of color blindness.

Much more rarely, a person may inherit a trait that reduces the ability to see blue and yellow hues. This blue-yellow color deficiency usually affects men and women equally.

Signs and Symptoms

Contrary to popular belief, it is rare for a color blind person to see only in shades of gray.

Most people who are considered "color blind" can see colors, but certain colors appear washed out and are easily confused with other colors, depending on the type of color vision deficiency they have.

What causes color blindness?

Color blindness occurs when light-sensitive cells in the retina fail to respond appropriately to variations in wavelengths of light that enable people to see an array of colors.

Besides differences in genetic makeup, other causes of color vision defects or loss include:

Parkinson's disease (PD) which is a neurological disorder, light-sensitive nerve cells in the retina where vision processing occurs may be damaged and cannot function properly.

Cataracts is the clouding of the eye's natural lens that can "wash out" color vision, making it much less bright.

Leber's Hereditary Optic Neuropathy (LHON) a type of inherited optic neuropathy can affect even carriers who don't have other symptoms but do have a degree of color blindness. Red-green color vision defects primarily are noted with this condition.

The journal invites different types of articles including original research article, review articles, short note communications, case reports, Editorials, letters to the Editors and expert opinions & commentaries from different regions for publication.

A standard editorial manager system is utilized for manuscript submission, review, editorial processing and tracking which can be securely accessed by the authors, reviewers and editors for monitoring and tracking the article processing. Manuscripts can be uploaded directly through mail id: ophthalmologist@eclinicalsci.com or forwarded to the Editorial Office at  https://www.pulsus.com/ophthalmologist-clinical-therapeutic-journal.html

How we work:

  • After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days.
  • A 21 day window time frame is allotted for peer-review process wherein multiple experts are contacted.
  • Author proof is generated within 7 working days after the acceptance decision.

Benefits on Publication:

Open Access: Permanent free access to your article upon publication ensures extensive global reach and readership.

Easy Article Sharing: Our open access enables you to share your article directly with colleagues through email and on social media via a single link, permitting third party reuse with appropriate citation in addition to the retention of content copyright by the author.

Global Marketing: Through promotion in a targeted global email announcement or press release, your article will be seen by thousands of the top-most thought-leaders in your field.

Colour Art: In a world of black & white journal articles, high-quality full-colour images make your article stand out from the crowd and tell a complete story, increasing readers and citations.

Social Media Exposure: Extended reach for your article through links on Twitter accounts provides maximum visibility worldwide.

Reprints: Distribute your work to colleagues and at conferences as we provide hard copy colour reprints of your article on order.


Media Contact:
Sarah Rose
Journal Manager
The Ophthalmologist: Clinical and Therapeutic Journal 

Email: ophthalmologist@eclinicalsci.com
Watsapp:+44-1470-490003